Yongsub Choi | Cardiovascular Disease | Best Researcher Award

Dr. Yongsub Choi | Cardiovascular Disease | Best Researcher Award

Dr. Yongsub Choi, Bellin Memorial Hospital, South Korea

Dr. Yongsub Choi is a dedicated internal medicine physician at Bellin Memorial Hospital, Green Bay, WI. He completed his MBBS (Summa Cum Laude) from Harbin Medical University, China, and an Internal Medicine Residency at BronxCare Health System, NYC. With extensive research experience in cardiology, nephrology, and gastroenterology, he has contributed to advancements in ventricular arrhythmia, atrial fibrillation, and liver recovery. Dr. Choi’s diverse background includes leadership roles, international medical practice, and teaching. His commitment to patient care, research, and global healthcare improvement makes him a distinguished figure in the field of internal medicine.

AUTHOR PROFILE

Scopus Profile

Orcid Profile

🎓EARLY ACADEMIC PURSUITS:

Dr. Yongsub Choi’s academic journey is marked by excellence and dedication. He earned his Bachelor of Medicine, Bachelor of Surgery (MBBS) from Harbin Medical University, China, graduating Summa Cum Laude. His academic excellence was evident throughout his studies, securing the First Prize Scholarship multiple times (2008-2009, 2011-2014). Prior to his medical education, he pursued Theology and Anthropology at Don Bosco Center of Studies, Manila, Philippines, where he graduated Cum Laude. Additionally, he completed his Bachelor of Philosophy (B.Ph) at Gwangju Catholic University, South Korea.

🏥PROFESSIONAL ENDEAVORS:

Dr. Choi has built a dynamic and diverse career in internal medicine, research, and leadership. Currently, he serves as a Hospitalist at the Department of Internal Medicine, Apogee Physicians, Bellin Memorial Hospital, Green Bay, WI (April 2023 – Present). His previous medical roles include:

  • Resident Physician at BronxCare Health System, NYC, USA (Feb 2020 – Jan 2023)
  • Locum Intern at Savanna-La-Mar Public General Hospital, Jamaica (Jan – June 2019)

In addition to his medical career, he held leadership roles such as:

  • Acting Executive Director (Apr 2007 – Feb 2008) at International Cooperational Technical High School, Yanji, China
  • English Teacher at Baosigao Technical High School, Taiwan
  • Assistant Parish Priest at Gurosamdong Parish, South Korea
  • Private Soldier in the Republic of Korea Army, Cheolwon, South Korea

🔬CONTRIBUTIONS AND RESEARCH FOCUS ON CARDIOVASCULAR DISEASE:

Dr. Choi’s contributions to medical research have significantly impacted the fields of cardiology, nephrology, and gastroenterology. His research roles include:

Research AssistantFirst Affiliated Hospital of Harbin Medical University, China

  • Investigated modulation of activated astrocytes in the hypothalamus paraventricular nucleus to prevent ventricular arrhythmia during acute myocardial infarction (July 2019 – Jan 2020).
  • Explored sonodynamic therapy for atrial fibrillation (AF) using a rabbit model (Mar 2017 – June 2018).
  • Studied mesenchymal stem cells with enhanced Bcl-2 expression to improve liver recovery in hepatic cirrhosis (July 2014 – Feb 2017).

Research ScholarAlbert Einstein College of Medicine, Bronx, NY

  • Focused on nephrology-related research under Dr. Victor L. Schuster, M.D. (June 2018 – Dec 2018).

🌍IMPACT AND INFLUENCE:

Dr. Choi’s work bridges clinical practice, academia, and international healthcare initiatives. His contributions extend beyond medical practice to mentorship, leadership, and medical education. His experience in multiple countries (USA, China, Jamaica, Taiwan, South Korea, and the Philippines) highlights his global perspective on healthcare and medical research.

🏅ACADEMIC CITES AND HONORS:

Dr. Choi has received numerous awards and recognitions:
Graduated Summa Cum Laude – Harbin Medical University (2014)
First Prize Scholarship (Top Student) – Harbin Medical University (2008-09, 2011-14)
Secretary of Class of 2008 – Harbin Medical University (2012-2014)
Cum Laude – Don Bosco Center of Studies, Manila, Philippines (2001)

🚀LEGACY AND FUTURE CONTRIBUTIONS:

Dr. Choi continues to shape the future of internal medicine and medical research. His extensive experience in cardiology, nephrology, and gastroenterology positions him as a key contributor to advancements in patient care and treatment methodologies. Moving forward, he aims to:

Enhance clinical excellence through evidence-based medicine.
Contribute to medical education and mentorship.
Advance research in cardiovascular and metabolic diseases.
Improve healthcare accessibility and quality in underprivileged regions.

 🌟CONCLUSION:

Dr. Yongsub Choi’s journey is a testament to dedication, excellence, and global impact in internal medicine and research. His expertise in cardiology, nephrology, and gastroenterology has contributed to significant advancements in patient care. With a strong foundation in clinical practice, leadership, and education, he continues to inspire future medical professionals. His commitment to evidence-based medicine, mentorship, and international healthcare development reflects his passion for improving lives worldwide. As he moves forward, Dr. Choi remains a trailblazer in internal medicine, striving for innovation and excellence in patient care and medical research.

TOP NOTABLE PUBLICATION

Probability assessment of pulmonary embolism using clinical and laboratory variables in hospitalized patients: A single-center, retrospective observational study

Authors: Y. Choi, Yongsub; N. Prasai, Neeti; T. Bhatt, Tanushree; A. Latif, Amber; M. Khaja, Misbahuddin

Journal: Thrombosis Update

Year: 2024

Christina Antza | Hypertension | Best Research Article Award

Assist. Prof. Dr. Christina Antza | Hypertension | Best Research Article Award

Assist. Prof. Dr. Christina Antza, 3rd Department of Internal Medicine, Aristotle University of Thessaloniki, Greece

Assist. Prof. Dr. Christina Antza is a specialist in Internal Medicine and Hypertension at the 3rd Department of Internal Medicine, Aristotle University of Thessaloniki, Greece. She holds an M.D., a Ph.D. in blood pressure measurement methods, and an M.Sc. in Research Methodology. Dr. Antza has extensive experience in hypertension, metabolic syndrome, diabetes, and atherosclerosis. She has worked as a researcher, consultant, and medical educator in Greece and the UK. Recognized with multiple awards and fellowships, she actively contributes to international medical research and education, shaping advancements in cardiovascular and metabolic disease management.

AUTHOR PROFILE

Orcid Profile

🎓 EARLY ACADEMIC PURSUITS:

Dr. Christina Antza began her educational journey at the Fifth High-School of Drama (Junior High School) and Third High School of Drama (Senior High School). She then pursued her Medical Degree at Aristotle University of Thessaloniki, Greece (2007-2013), graduating with an impressive 8/10 grade.

Her passion for research and academia led her to further studies, including:

  • Ph.D. in Internal Medicine (2014-2019) – Focused on blood pressure measurement methods and their ability to predict early vascular aging. She earned a Grade A with Distinction under the supervision of Prof. V. Kotsis.
  • Master of Science in Research Methodology in Medicine and Health Science (2016-2018) – Achieved an outstanding 9/10 grade.
  • Research Fellowship (2019-2020) – Conducted clinical and research work in Diabetes Mellitus and Obesity at the University of Birmingham, UK.
  • Postdoctoral Research (2019-2022) – Specialized in Hypertension and Metabolic Syndrome at Aristotle University of Thessaloniki.
  • Internal Medicine Consultant Certification (2021) – Earned after passing rigorous written and oral examinations.

💼 PROFESSIONAL ENDEAVORS:

Dr. Antza has held various prestigious roles in internal medicine, focusing on hypertension, metabolic syndrome, and endocrinology:

  • Scientific Associate (2013-2014) – Engaged in research and clinical practice in hypertension at the 3rd Department of Internal Medicine, Aristotle University of Thessaloniki.
  • Medical Resident (2016-2021) – Trained at Papageorgiou General Hospital, Aristotle University of Thessaloniki.
  • Academic Fellowship in Hypertension & Metabolic Syndrome (2021-2022) – Focused on clinical practice, independent teaching, and research.
  • Internal Medicine Consultant (2021-2023) – Served at Papageorgiou General Hospital and Bioclinic, offering expertise in hypertension, diabetes, and emergency medicine.
  • Assistant Professor of Internal Medicine – Hypertension (2023-Present) – Currently educating future medical professionals and leading research at Aristotle University of Thessaloniki.

Additionally, she has participated as a Subinvestigator in Phase 2 & 3 Clinical Trials, contributing to advancements in hypertension and metabolic disorders.

📚 CONTRIBUTIONS AND RESEARCH FOCUS ON HYPERTENSION:

Dr. Antza has extensively researched hypertension, metabolic syndrome, diabetes, lipid disorders, and vascular aging. Her work has focused on:

  • Blood Pressure Measurement Techniques (Home, Ambulatory, and Clinical).
  • Atherosclerosis and Cardiovascular Risk.
  • Metabolic Syndrome and Obesity-Related Disorders.
  • Diabetes and Endocrine Disorders.

She has been actively involved in research collaborations with leading medical institutions, including Queen Elizabeth Hospital, Birmingham, UK, where she served as an Honorary Observer (2019-2022) in the Endocrinology Department.

🏆 IMPACT AND INFLUENCE:

Dr. Antza’s work has been recognized with numerous awards and fellowships:

  • Young Fellow of the European Atherosclerosis Society (2019-Present).
  • Young Fellow of the European Hypertension Society (2023-Present).
  • Recipient of multiple Investigator Grants & Travel Awards from the European Society of Hypertension (ESH) and European Atherosclerosis Society (EAS).
  • 1st Place Oral Presentation Award – 8th Panhellenic Congress of the Hellenic Atherosclerosis Society (2019).
  • 2nd Clinical Research Award – 9th Panhellenic Congress of the Hellenic Atherosclerosis Society (2020).
  • Young Investigator Fellowship Award – 89th EAS Virtual Congress (2021).

📖 ACADEMIC CITATIONS & SCHOLARSHIPS:

Dr. Antza’s research has been widely cited in medical literature, influencing clinical guidelines in hypertension and metabolic diseases. Her scholarly excellence has earned her:

  • Ph.D. Scholarship from the Hellenic Society of Atherosclerosis (2014-2015).
  • Postdoctoral Research Scholarship from the State Scholarship Foundation (2019-2021).
  • Award from the Medical Sciences Deanery for Ph.D. Research (2020).

🌍 LEGACY AND FUTURE CONTRIBUTIONS:

Dr. Christina Antza is poised to make significant future contributions in the diagnosis and management of hypertension, metabolic syndrome, and cardiovascular diseases. Her expertise in clinical research, education, and innovative treatment strategies will continue to shape internal medicine and patient care.

Her future goals include:
✔ Expanding research on hypertension-related complications and vascular aging.
✔ Leading international collaborations in cardiovascular and metabolic diseases.
✔ Mentoring the next generation of medical professionals and researchers.
✔ Contributing to global guidelines on hypertension and cardiovascular risk management.

Her dedication to patient care, research, and teaching makes her an influential figure in modern internal medicine and hypertension research.

🌟CONCLUSION :

Assist. Prof. Dr. Christina Antza is a dedicated clinician, researcher, and educator in the fields of hypertension, metabolic syndrome, and internal medicine. With a strong academic foundation, international research collaborations, and numerous accolades, she continues to advance medical knowledge and improve patient care. Her contributions to medical education and research have made a lasting impact, inspiring future generations of physicians. As she progresses in her career, Dr. Antza remains committed to innovation, scientific discovery, and excellence in healthcare, shaping the future of cardiovascular and metabolic disease management. Her work stands as a testament to dedication and expertise.

TOP NOTABLE PUBLICATIONS

Clinic, Ambulatory and Home Blood Pressure Monitoring for Metabolic Syndrome: Time to Change the Definition?

Journal: Medicina

Year: 2025

The Microbial Perspective: A Systematic Literature Review on Hypertension and Gut Microbiota

Journal: Nutrients

Year: 2024

The Effects of Olive Oil Consumption on Biochemical Parameters and Body Mass Index of People with Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Journal: Nutrients

Year: 2024

Familial Hypercholesterolemia in the Elderly: An Analysis of Clinical Profile and Atherosclerotic Cardiovascular Disease Burden from the Hellas-FH Registry

Journal: Biomedicines

Year: 2024

The Modern Environment: The New Secondary Cause of Hypertension?

Journal: Medicina

Year: 2023

The Importance of Out-of-Office Blood Pressure Measurement, as Highlighted by the Correlation with Left Ventricular Hypertrophy in an Untreated Hypertensive Population

Journal: Medicina

Year: 2023